Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
| $4.12M | ﹤0.01% |
70,770
+48,823
| +222% | +$2.85M |
|
|
MRSH
3102
CALL
Marsh
MRSH
$89.6B
| $4.12M | ﹤0.01% |
49,800
-7,600
| -13% | -$644K |
|
|
FNSR
3103
PUT
DELISTED
Finisar Corp
FNSR
| $4.12M | ﹤0.01% |
216,000
-20,000
| -8% | -$372K |
|
3104
Karyopharm Therapeutics
KPTI
$45.8M
| $4.11M | ﹤0.01% |
16,074
+4,317
| +37% | +$1.19M |
|
3105
Xylem
XYL
$27.9B
| $4.11M | ﹤0.01% |
+51,391
| New | +$3.84M |
|
3106
Forum Energy Technologies
FET
$960M
| $4.1M | ﹤0.01% |
19,822
+18,492
| +1,390% | +$4.36M |
|
|
JCP
3107
DELISTED
J.C. Penney Company, Inc.
JCP
| $4.09M | ﹤0.01% |
2,465,869
+2,027,078
| +462% | +$4.3M |
|
3108
Planet Fitness
PLNT
$3.8B
| $4.09M | ﹤0.01% |
75,744
+56,556
| +295% | +$2.81M |
|
3109
CALL
Fair Isaac
FICO
$23.5B
| $4.09M | ﹤0.01% |
17,900
-5,300
| -23% | -$1.15M |
|
3110
KKR & Co
KKR
$102B
| $4.09M | ﹤0.01% |
150,000
+805
| +0.5% | +$21.5K |
|
3111
CALL
Amphenol
APH
$206B
| $4.09M | ﹤0.01% |
174,000
+70,800
| +69% | +$1.65M |
|
3112
CALL
Quest Diagnostics
DGX
$25.9B
| $4.09M | ﹤0.01% |
37,900
+8,700
| +30% | +$954K |
|
3113
Gentherm
THRM
$1.35B
| $4.09M | ﹤0.01% |
89,942
-92,134
| -51% | -$4.18M |
|
|
AVP
3114
DELISTED
Avon Products, Inc.
AVP
| $4.09M | ﹤0.01% |
1,857,565
-457,762
| -20% | -$844K |
|
3115
PUT
iShares MSCI China ETF
MCHI
$6.16B
| $4.08M | ﹤0.01% |
68,200
-19,100
| -22% | -$1.17M |
|
3116
PUT
TC Energy
TRP
$66.7B
| $4.08M | ﹤0.01% |
100,900
+75,800
| +302% | +$3.29M |
|
3117
PUT
Tyler Technologies
TYL
$13.5B
| $4.07M | ﹤0.01% |
16,600
-11,300
| -41% | -$2.69M |
|
|
HZNP
3118
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.07M | ﹤0.01% |
207,719
+192,926
| +1,304% | +$3.67M |
|
3119
CALL
Northern Trust
NTRS
$35B
| $4.07M | ﹤0.01% |
39,800
-2,400
| -6% | -$257K |
|
3120
CALL
Protolabs
PRLB
$2.2B
| $4.06M | ﹤0.01% |
25,100
+8,500
| +51% | +$1.2M |
|
3121
First Bancorp
FBP
$4.53B
| $4.06M | ﹤0.01% |
+446,040
| New | +$3.78M |
|
3122
Charles River Laboratories
CRL
$13.4B
| $4.05M | ﹤0.01% |
30,142
+25,892
| +609% | +$3.2M |
|
3123
PUT
Red Robin
RRGB
$192M
| $4.05M | ﹤0.01% |
101,000
+64,500
| +177% | +$2.74M |
|
3124
Duluth Holdings
DLTH
$153M
| $4.05M | ﹤0.01% |
128,795
-101,702
| -44% | -$2.78M |
|
3125
CALL
EQT Corp
EQT
$34B
| $4.05M | ﹤0.01% |
168,269
-39,863
| -19% | -$1.1M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.